NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $27,919,000 | +101.3% | 2,326,544 | 0.0% | 2.97% | +125.1% |
| Q4 2016 | $13,866,000 | +76.1% | 2,326,544 | +108.3% | 1.32% | +89.0% |
| Q3 2016 | $7,872,000 | -0.5% | 1,116,660 | +5.9% | 0.70% | -15.8% |
| Q2 2016 | $7,911,000 | +0.9% | 1,054,823 | +20.6% | 0.83% | -3.4% |
| Q1 2016 | $7,840,000 | -6.9% | 874,985 | 0.0% | 0.86% | +6.2% |
| Q4 2015 | $8,417,000 | +2.2% | 874,985 | +0.9% | 0.81% | -4.9% |
| Q3 2015 | $8,238,000 | – | 867,127 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,021,559 | $23,968,000 | 7.90% |
| Omega Fund Management, LLC | 1,145,890 | $6,830,000 | 5.54% |
| ACUTA CAPITAL PARTNERS, LLC | 706,383 | $4,210,000 | 1.57% |
| Novo Holdings A/S | 2,326,544 | $13,866,000 | 1.32% |
| FT Options LLC | 83,055 | $494,000 | 0.57% |
| EcoR1 Capital, LLC | 264,773 | $1,578,000 | 0.50% |
| Boxer Capital, LLC | 176,710 | $1,053,000 | 0.41% |
| Rock Springs Capital Management LP | 525,000 | $3,124,000 | 0.21% |
| Orbimed Advisors | 1,677,940 | $10,001,000 | 0.13% |
| Hillhouse Capital Management | 700,000 | $4,165,000 | 0.09% |